Vijoice Tablet
Product Images NDC 0078-1021

This text is a product description of a medication called "Vijoice", which contains 50 mg of alpelisib, manufactured by Novartis Pharma Stain AG in Switzerland and distributed by Novartis Pharmaceuticals Corporation in New Jersey, USA. The medication is intended for oral use and the recommended dosage is one 50 mg tablet once daily with food. The tablets should not be chewed, crushed, or split. The medication comes in a blister pack containing 28 tablets and should be stored at 20°C to 25°C (68°F to 77°F), with excursions permitted between 15°C and 30°C (50°F and 86°F) in the original package to keep away from children. For more information, there is a website link and phone number provided.*

Vijoice tablets containing alpelisib (125 mg) are a prescription medication indicated for oral use to treat certain types of breast cancer. The medication is manufactured by Novartis Pharma Stain AG in Switzerland and distributed by Novartis Pharmaceuticals Corporation in the US. The medication should be taken once daily with food and swallowed whole. The medication is not suitable for chewing, crushing or splitting. Detailed prescribing information is available for those who cannot swallow the tablets whole. The medication should be stored at temperatures between 20°C to 25°C (68°F to 77°F). The packaging contains a 28-day supply and the medication should be kept out of reach of children. For more information, patients are advised to refer to the product website or contact Novartis Pharmaceuticals Corporation customer support.*

This is a description of Vijoice, a medication made by Novartis Pharma Stein AG of Switzerland and distributed by Novartis Pharmaceuticals Corporation of New Jersey. This is a recommended medication for oral use and should be taken by swallowing one 200 mg tablet and one 50 mg tablet whole once daily with food. It is important not to crush, chew, or split the tablets. Vijoice comes in two 14-day blister packs each containing 28 tablets. The prescribing information contains complete dosage information and instructions for patients who are unable to swallow tablets. The storage temperature should be between 20°C to 25°C (68°F to 77°F) and out of the reach of children. For more information, visit www.VIOICE.com or call 1-888-669-6682.*